Study guide
4.3 PW and CW Spectral Doppler Acquisition
CCI Registered Cardiac Sonographer RCS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: RCS Orientation and Clinical Context
1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context
2 Chapter 2: Orders, Safety, and Patient Preparation
2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare
3 Chapter 3: Reporting and 2-D TTE Foundations
3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA
4 Chapter 4: M-Mode and Doppler Acquisition
4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition
5 Chapter 5: Advanced Doppler and Contrast
5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts
6 Chapter 6: Stress Echocardiography
6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation
7 Chapter 7: TEE, Strain, and 3-D TEE
7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts
8 Chapter 8: 3-D TTE and the Aortic Valve
8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States
9 Chapter 9: Aortic Regurgitation and Mitral Structure
9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability
10 Chapter 10: Mitral and Tricuspid Valve Findings
10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment
11 Chapter 11: Right-Sided Valve Disease
11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment
12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves
12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch
13 Chapter 13: Endocarditis and Cardiac Chambers
13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function
14 Chapter 14: Cardiomyopathy Phenotypes and Diastology
14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls
15 Chapter 15: Systolic Function and Ischemia
15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications
16 Chapter 16: Pericardium and Great Vessels
16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation
17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition
17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues
18 Chapter 18: Devices, Strain, and Hemodynamics
18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts
19 Chapter 19: Infiltrative Disease and Physics Foundations
19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing
20 Chapter 20: Resolution and Doppler Optimization
20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain
21 Chapter 21: 2-D, 3-D, and Contrast Optimization
21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts
4.3 PW and CW Spectral Doppler Acquisition
Key Takeaways Explain This Topic AI
PW Doppler provides range specificity at a selected sample volume but aliases above its Nyquist limit; CW records high velocities without aliasing but cannot identify depth along the beam.
Align the Doppler cursor as parallel as possible to flow and seek the highest valid velocity from multiple windows rather than applying angle correction in routine echocardiography.
Place a small PW gate at the protocol-defined anatomic site, then adjust scale, baseline, gain, wall filter, and sweep speed until timing and the modal envelope are unambiguous.
Treat aliasing by deciding whether location or maximum velocity is the real question; change depth, PRF, frequency, baseline, HPRF, or modality accordingly.
Reject contaminated, overgained, undergained, postectopic, or poorly aligned spectra before tracing a peak velocity or VTI.
Last updated: July 2026
Choose the mode that answers the sampling question
CCI task B4 includes spectral Doppler acquisition. Pulsed-wave Doppler (PW) sends pulses and listens after a delay, so a sample volume can be placed at a known depth. That range specificity is essential for mitral inflow, pulmonary-vein flow, LVOT or RVOT velocity, and mapping a region of acceleration. Its maximum measurable shift is limited: the Nyquist limit equals one-half the pulse-repetition frequency (PRF). Continuous-wave Doppler (CW) transmits and receives continuously. It records very high velocities without aliasing, but every moving reflector along the beam contributes, so there is no range resolution. CW is suited to stenotic and regurgitant jets when maximum velocity matters.
- Feature PW Doppler CW Doppler Acquisition consequence
- Sampling Defined gate at a chosen depth Entire beam path PW localizes; CW may mix multiple flows
- High velocity Aliases above Nyquist No aliasing limit of PW type Use CW for a complete high-velocity envelope
Placement Gate position and size are critical Beam alignment and window are critical Color can guide both, but must not replace spectral confirmation
Typical use Inflow, venous flow, outflow VTI, flow mapping Valve stenosis, regurgitation, high-velocity obstruction Choose by the question, not by waveform brightness
Main pitfall Wrong depth or a gate spanning mixed velocities Lack of range resolution and contamination from multiple flows Recheck anatomy, timing, and alternate windows
Alignment precedes every control adjustment
The Doppler equation includes the cosine of the angle between beam and flow. Maximum velocity is recorded when they are parallel; increasing deviation causes underestimation. Color helps locate and align a jet in the imaging plane but cannot reveal every three-dimensional component. ASE guidance recommends interrogating valves and other flows from multiple planes, using the window that produces the highest valid velocity rather than averaging lower, misaligned values. Routine echocardiographic angle-correction software is not recommended as a substitute for alignment. For suspected aortic stenosis, use apical, right-parasternal, suprasternal, or other appropriate windows and a dedicated nonimaging CW transducer when needed.
Start with a visible scale and baseline that show the complete waveform. Set spectral gain high enough to define the dense modal signal, then reduce it if background noise, spectral fill-in, or a falsely thick border obscures the envelope. Undergain can erase the true peak; overgain can make weak clutter look traceable. Use wall filter low enough to retain clinically relevant low velocities but high enough to suppress wall motion for the selected application. Faster sweep speeds separate timing, slopes, and VTI boundaries; slower speeds show respiration or more cycles. Preserve the ECG and record sufficient beats for the rhythm and maneuver. Avoid postectopic beats and follow disease-specific guidance for averaging irregular cycles.
Place the PW sample volume deliberately
A PW gate answers, What is velocity here? For mitral inflow, place a small sample at the leaflet tips where the E and A envelopes are clean; moving toward the annulus changes the recorded velocities. For LVOT stroke-volume acquisition, ASE/EACVI aortic-stenosis guidance uses a roughly 3–5 mm gate just proximal to the aortic valve and proximal to flow acceleration. Move the gate slowly from the valve toward the apex until a smooth, narrow systolic envelope is obtained. A broad signal or strong acceleration indicates sampling too close to the valve; a closing click can help confirm proximity but the waveform must remain laminar. The LVOT diameter used later should correspond to the sampling level.
Sample-volume size is not merely cosmetic. A gate that is too large spans more velocity components and causes spectral broadening; a very small gate may be weak or miss a moving target. Center the gate in the flow stream, watch it throughout respiration, and reacquire if motion changes its anatomic location. For pulmonary, hepatic, and tricuspid inflow signals, record the respiratory interval required by protocol rather than freezing the most convenient beat. Label window, mode, sample site, and maneuver.
Diagnose aliasing before trying to remove it
In PW spectral aliasing, the waveform is cut off at one edge and wraps to the opposite side, making peak velocity and direction ambiguous. It is a sampling phenomenon, not proof of turbulence. The 2026 ASE artifact guideline emphasizes that greater sample depth restricts maximum PRF because the pulse must travel out and back. When location-specific velocity is still the goal, reduce depth if a safe alternate window allows, raise scale/PRF, lower transmitted frequency, or shift the baseline toward the direction of interest. Baseline shift expands display in one direction but does not increase the total Nyquist span.
High-PRF Doppler uses multiple sample gates to extend the measurable range, trading away unique range specificity and introducing range ambiguity. It can help map acceleration, but it is not equivalent to CW or ordinary PW. If the clinical question is the maximum velocity of a high-speed jet, switch to CW and optimize alignment instead of repeatedly forcing PW settings. Conversely, do not use a CW envelope for LVOT VTI in the continuity equation: the CW beam includes accelerated and valvular velocities from multiple depths.
Before tracing, verify: correct mode, correct site or window, near-parallel cursor, complete envelope, appropriate scale and sweep, clean modal border, representative beats, and matching ECG timing. A calculation made from the wrong spectrum is more misleading than no calculation.